SG47035A1 - Method of topically treating acne vulgaris - Google Patents
Method of topically treating acne vulgarisInfo
- Publication number
- SG47035A1 SG47035A1 SG1996003667A SG1996003667A SG47035A1 SG 47035 A1 SG47035 A1 SG 47035A1 SG 1996003667 A SG1996003667 A SG 1996003667A SG 1996003667 A SG1996003667 A SG 1996003667A SG 47035 A1 SG47035 A1 SG 47035A1
- Authority
- SG
- Singapore
- Prior art keywords
- topically treating
- acne vulgaris
- treating acne
- ketoconazole
- compositions
- Prior art date
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract 2
- 206010000496 acne Diseases 0.000 title abstract 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 abstract 2
- 229960004125 ketoconazole Drugs 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010051246 Photodermatosis Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001329 hyperkeratotic effect Effects 0.000 abstract 1
- 230000008845 photoaging Effects 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pain & Pain Management (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898910069A GB8910069D0 (en) | 1989-05-03 | 1989-05-03 | Method of topically treating acne vulgaris |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG47035A1 true SG47035A1 (en) | 1998-03-20 |
Family
ID=10656092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996003667A SG47035A1 (en) | 1989-05-03 | 1990-04-26 | Method of topically treating acne vulgaris |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0396184B1 (pt) |
| JP (1) | JP2833711B2 (pt) |
| KR (1) | KR0161526B1 (pt) |
| AT (1) | ATE145136T1 (pt) |
| AU (1) | AU626672B2 (pt) |
| CA (1) | CA2015838C (pt) |
| DE (1) | DE69029100T2 (pt) |
| DK (1) | DK0396184T3 (pt) |
| ES (1) | ES2096577T3 (pt) |
| GB (1) | GB8910069D0 (pt) |
| GR (1) | GR3022519T3 (pt) |
| IE (1) | IE74192B1 (pt) |
| IL (1) | IL94267A (pt) |
| PT (1) | PT93935B (pt) |
| SG (1) | SG47035A1 (pt) |
| ZA (1) | ZA903339B (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5583136A (en) * | 1990-01-29 | 1996-12-10 | Johnson & Johnson Consumer Products, Inc. | Retinoid containing skin care compositions containing imidazoles |
| US5559149A (en) | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
| GB9014221D0 (en) * | 1990-06-26 | 1990-08-15 | Janssen Pharmaceutica Nv | Method of treating alopecia |
| LU87843A1 (fr) * | 1990-11-15 | 1992-08-25 | Cird Galderma | Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique |
| GR1002207B (en) * | 1992-08-06 | 1996-03-27 | Johnson & Johnson Consumer | Skin care compositions containing imidazoles. |
| WO1994014447A1 (en) * | 1992-12-22 | 1994-07-07 | Sepracor, Inc. | Methods and compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections |
| ES2064288B1 (es) * | 1993-07-06 | 1995-08-01 | Ornosa Enrique Viayna | Composicion para el tratamiento de afecciones cutaneas, su preparacion y su uso. |
| TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
| US5556871A (en) * | 1995-04-24 | 1996-09-17 | President & Fellows Of Harvard College | Method for treating epithelial precancerous lesions with topical inidazoles |
| GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
| US5716627A (en) * | 1996-04-25 | 1998-02-10 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester |
| US6150403A (en) * | 1997-10-14 | 2000-11-21 | The Procter & Gamble Company | Topical compositions for regulating the oily/shiny appearance of skin |
| KR100247558B1 (ko) * | 1997-11-24 | 2000-05-01 | 김충섭 | 사이클로덱스트린을 이용한 이온토포레시스 개선방법 |
| RU2120305C1 (ru) * | 1997-11-27 | 1998-10-20 | Открытое акционерное общество Химико-фармацевтический комбинат "Акрихин" | Фармацевтический состав, обладающий противогрибковой активностью, и способ его получения |
| US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
| US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
| DE19943678A1 (de) * | 1999-09-13 | 2001-03-15 | Beiersdorf Ag | Wirkstoffkombinationen aus oberflächenaktiven Citronensäureestern und Einschlußverbindungen von Cyclodextrinen und Retinoiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen |
| GB2365770B (en) * | 2000-08-18 | 2002-07-31 | Diomed Dev Ltd | Antifungal ketoconazole composition for topical use |
| DE10131796A1 (de) * | 2001-06-30 | 2003-01-16 | Beiersdorf Ag | Verwendung von Cardiolipin in kosmetischen oder dermatologischen Zubereitungen |
| DE10151245A1 (de) * | 2001-10-17 | 2003-05-15 | Beiersdorf Ag | Kosmetische und/oder dermatologische Wirkstoffkombination |
| KR100432449B1 (ko) * | 2001-11-30 | 2004-05-22 | 우원홍 | 케토코나졸 함유 피부 미백용 외용제 조성물 |
| FR2835434B1 (fr) * | 2002-02-01 | 2006-03-03 | Lvmh Rech | Utilisation cosmetique ou dermatologique de la vitamine a ou de ses esters, en association avec une beta-cyclodextrine partiellement methylee |
| EP2005954B8 (en) * | 2006-03-23 | 2012-11-28 | TMRC Co., Ltd. | Kit for cancer therapy and pharmaceutical composition for cancer therapy |
| WO2013107809A1 (en) * | 2012-01-19 | 2013-07-25 | Merz Pharma Gmbh & Co. Kgaa | Use of azole antifungals for the treatment of actinic keratosis |
| CN108066342A (zh) * | 2016-11-17 | 2018-05-25 | 江苏灵豹药业股份有限公司 | 一种复方酮康唑乳膏剂及其制备方法 |
| CN115671285B (zh) * | 2022-08-24 | 2024-01-05 | 上海市皮肤病医院 | 一种抗真菌溶液及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| GB2068228B (en) * | 1980-01-24 | 1984-02-29 | Janssen Pharmaceutica Nv | Anti-microbial compositions for the topical treatment of acne vulgaris |
| US4371673A (en) * | 1980-07-21 | 1983-02-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble forms of retinoids |
| GB2097783B (en) * | 1981-04-23 | 1984-12-12 | Dermal Lab Ltd | Imidazoles |
| US4569935A (en) * | 1983-03-17 | 1986-02-11 | University Of Tennessee Research Corp. | Topical treatment of psoriasis with imidazole antibiotics |
| DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
| EP0270316A3 (en) * | 1986-12-04 | 1989-12-06 | Pfizer Inc. | Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne |
| US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
-
1989
- 1989-05-03 GB GB898910069A patent/GB8910069D0/en active Pending
-
1990
- 1990-04-26 ES ES90201054T patent/ES2096577T3/es not_active Expired - Lifetime
- 1990-04-26 DE DE69029100T patent/DE69029100T2/de not_active Expired - Fee Related
- 1990-04-26 SG SG1996003667A patent/SG47035A1/en unknown
- 1990-04-26 EP EP90201054A patent/EP0396184B1/en not_active Expired - Lifetime
- 1990-04-26 AT AT90201054T patent/ATE145136T1/de not_active IP Right Cessation
- 1990-04-26 DK DK90201054.5T patent/DK0396184T3/da active
- 1990-05-01 CA CA002015838A patent/CA2015838C/en not_active Expired - Fee Related
- 1990-05-02 IE IE160790A patent/IE74192B1/en not_active IP Right Cessation
- 1990-05-02 JP JP2115340A patent/JP2833711B2/ja not_active Expired - Fee Related
- 1990-05-02 PT PT93935A patent/PT93935B/pt not_active IP Right Cessation
- 1990-05-02 IL IL9426790A patent/IL94267A/en not_active IP Right Cessation
- 1990-05-02 AU AU54711/90A patent/AU626672B2/en not_active Ceased
- 1990-05-02 ZA ZA903339A patent/ZA903339B/xx unknown
- 1990-05-03 KR KR1019900006234A patent/KR0161526B1/ko not_active Expired - Fee Related
-
1997
- 1997-02-12 GR GR960403427T patent/GR3022519T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69029100T2 (de) | 1997-04-03 |
| KR0161526B1 (ko) | 1998-12-01 |
| IE901607L (en) | 1990-11-03 |
| EP0396184A3 (en) | 1992-05-20 |
| CA2015838A1 (en) | 1990-11-03 |
| JPH02295927A (ja) | 1990-12-06 |
| ES2096577T3 (es) | 1997-03-16 |
| ATE145136T1 (de) | 1996-11-15 |
| AU626672B2 (en) | 1992-08-06 |
| CA2015838C (en) | 2002-08-27 |
| ZA903339B (en) | 1992-01-29 |
| IE74192B1 (en) | 1997-07-16 |
| PT93935B (pt) | 1996-11-29 |
| JP2833711B2 (ja) | 1998-12-09 |
| AU5471190A (en) | 1990-11-15 |
| KR900017590A (ko) | 1990-12-19 |
| IL94267A0 (en) | 1991-03-10 |
| GB8910069D0 (en) | 1989-06-21 |
| GR3022519T3 (en) | 1997-05-31 |
| IL94267A (en) | 1994-11-11 |
| PT93935A (pt) | 1991-02-08 |
| EP0396184A2 (en) | 1990-11-07 |
| DE69029100D1 (de) | 1996-12-19 |
| EP0396184B1 (en) | 1996-11-13 |
| DK0396184T3 (da) | 1996-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE901607L (en) | Method of topically treating acne vulgaris | |
| EG20273A (en) | Process for preparing of pyrazolopyrimidines and their use in the treatment of stress related and other diseases | |
| AU2080988A (en) | Esters of 13-trans-retinoic acid | |
| IL94490A0 (en) | Stable,cosmetically acceptable topical gel formulation and method of treatment for acne | |
| HUT59000A (en) | Process for producing pharmaceutical preparations containing 4-phenyl-1,2,3,4-tetrahydro-1-naphtalinamine-derivatives | |
| CA2213339A1 (en) | Method of treating adenosine depletion | |
| HUT65754A (en) | Process for production of preparations containing complement inhibitors for treatment of inflammatory intestinal-and dermal-diseases | |
| AU3432989A (en) | Product and method for the treatment of acne etc. | |
| HUT63053A (en) | Process for producing pharmaceutical compositions comprising 9-cis-retinoic acid | |
| AU6857887A (en) | Therapeutic agent | |
| GR3026086T3 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
| HUT45960A (en) | Process for producing 2,4,5-trisubstituted derivatives of phenol of antiflogistic activity | |
| GR1002329B (el) | Μεθοδος για την παραγωγη αλατων κλαβουλανικου οξεος. | |
| IE830664L (en) | Treating acne | |
| PH31608A (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses. | |
| KR100226082B1 (en) | Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity | |
| ES2006121A6 (es) | Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas. | |
| IE870577L (en) | Topical amide preparation | |
| HU896587D0 (en) | 2-amino-carbonic acid derivatives, and medical preparations containing them as active agents, and process for the production of the active agents and the preparation | |
| HU9200792D0 (en) | Diphosphinic acid derivatives containing new amidine-groups, process for their production and medical preparations containing thereof | |
| HU213268B (en) | Process for producing pharmaceutical composition for treating dermatological diseases | |
| HU911307D0 (en) | Medicative preparation with natural active agent, primarily for treating varicose veins, and process for the producion of the preparation | |
| UA8280A (uk) | Спосіб лікування псоріазу | |
| PH25092A (en) | A method of preventing and treating renal diseases |